Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous

Código QR

Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous

Guardado en:

Detalles Bibliográficos
Autores principales:	Yashavanthi Mysore, Eva M. del Amo, Sirpa Loukovaara, Marja Hagström, Arto Urtti, Anu Kauppinen
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/78cc0357322842e3ad8e580c4944d9b4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
por: Yashavanthi Mysore, et al.
Publicado: (2021)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka A, et al.
Publicado: (2016)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka A, et al.
Publicado: (2012)

INCREASING STATIN USE IN DIABETICS FOR CVD PREVENTION
por: Karsh Gaurav, et al.
Publicado: (2021)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
por: Marina G. Bubnova, et al.
Publicado: (2021)

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
por: Shun-Hua Chen, et al.
Publicado: (2021)

Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
por: Tuuminen R, et al.
Publicado: (2016)

Statins and Insulin Resistance
por: GM Sanvee, et al.
Publicado: (2020)

Cerebrovascular Disease and Statins
por: Luis M. Beltrán Romero, et al.
Publicado: (2021)

Adherence and prescription of statin therapy in primary prevention in primary care unit
por: Juraj Jug, et al.
Publicado: (2021)

Treating statin-intolerant patients
por: Pigna G, et al.
Publicado: (2011)

Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021)

Statins and diabetes: focus on pitavastatin
por: Soreiia A. Urazgildeeva
Publicado: (2020)

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
por: Thongtang N, et al.
Publicado: (2020)

PREVENTIVE EFFECT OF LONG ACTING Β2-AGONISTS ON STATIN INDUCED MYOPATHIES
por: Abdullah Qamar, et al.
Publicado: (2018)

Prevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review
por: Behzad Heidari, et al.
Publicado: (2021)

Dashed line relaxing retinotomy in the management of retinal detachment with anterior proliferative vitreoretinopathy
por: Tsen CL, et al.
Publicado: (2015)

Relaxing retinotomies and retinectomies in the management of retinal detachment with severe proliferative vitreoretinopathy (PVR)
por: Khaled AG Shalaby
Publicado: (2010)

Epiretinal membrane and cystoid macular edema as predictive factors of recurrent proliferative vitreoretinopathy
por: Xu K, et al.
Publicado: (2017)

Statins and diabetes mellitus: price of collaboration
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2012)

Statin use and risk of diabetes mellitus
por: Oksana Mikhailovna Drapkina, et al.
Publicado: (2012)

Statins and risk of breast cancer recurrence
por: Sakellakis M, et al.
Publicado: (2016)

Are statins beneficial for the treatment of pulmonary hypertension?
por: Lei Wang, et al.
Publicado: (2017)

The potential effect of statins on rituximab immunotherapy.
por: Mark S Cragg
Publicado: (2008)

Pleiotropic effects of statins: New evidences
por: Kaan Okyay
Publicado: (2021)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin HS, et al.
Publicado: (2020)

Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
por: Kaku Itoh, et al.
Publicado: (2021)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Jihaeng Im, et al.
Publicado: (2021)

Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006.
por: Mariam Molokhia, et al.
Publicado: (2008)

Retinotomy with retinal turnover to remove subretinal membranes under direct visualization for proliferative vitreoretinopathy
por: Kimura M, et al.
Publicado: (2012)

Upregulation of ASPP2 expression alleviates the development of proliferative vitreoretinopathy in a rat model
por: Yan-Kun Yue, et al.
Publicado: (2021)

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
por: Ani Korhonen, et al.
Publicado: (2021)

Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis
por: Chen Chen, et al.
Publicado: (2021)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Yu-Cheng Kao, et al.
Publicado: (2021)

The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy
por: Yuichi Ikegami, et al.
Publicado: (2018)

Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy
por: Tlucek PS, et al.
Publicado: (2013)

SIMULTANEOUS QUANTITATION OF MOXIFLOXACIN AND STATINS INAPI BY RP-HPLC
por: Qamar,Fatima, et al.
Publicado: (2019)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Tracey M Ellimuttil, et al.
Publicado: (2021)

Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: Cormac McCarthy, et al.
Publicado: (2018)

Harnessing Therapeutic Potentials of Statins Using Nanofibrous Carriers
por: Mahshid Ataei, et al.
Publicado: (2021)